Interim Buprenorphine vs. Waiting List for Opioid Dependence
| Autor: | Robert P. Schwartz, Bryce Hruska, Brent A. Moore, Gary J. Badger, Sarah H. Heil, Andrew C. Meyer, John R Brooklyn, Gail L. Rose, Stacey C. Sigmon, Stephen T. Higgins, Taylor A. Ochalek |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2016 |
| Předmět: |
Narcotic antagonists
business.industry 030508 substance abuse General Medicine Urine Article law.invention 03 medical and health sciences 0302 clinical medicine Randomized controlled trial Opioid law Waiting list Interim Anesthesia medicine 030212 general & internal medicine 0305 other medical science business Buprenorphine medicine.drug |
| Popis: | In 50 opioid users on a waiting list for maintenance treatment, those assigned to interim treatment with buprenorphine submitted a higher percentage of urine specimens that were negative for illicit opioids than those in the control group at 4 weeks (88% vs. 0%), 8 weeks (84% vs. 0%), and 12 weeks (68% vs. 0%). |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|